LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 71 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $104,000 | -54.0% | 26,143 | -50.4% | 0.01% | -56.0% |
| Q2 2021 | $226,000 | +1.8% | 52,749 | -6.7% | 0.02% | -3.8% |
| Q4 2019 | $222,000 | +91.4% | 56,542 | +350.0% | 0.03% | +100.0% |
| Q2 2019 | $116,000 | -83.4% | 12,565 | -88.5% | 0.01% | -81.7% |
| Q1 2019 | $700,000 | +93.9% | 108,892 | +184.4% | 0.07% | +69.0% |
| Q4 2018 | $361,000 | +22.8% | 38,292 | +279.4% | 0.04% | +180.0% |
| Q2 2018 | $294,000 | -26.3% | 10,092 | -24.6% | 0.02% | -28.6% |
| Q1 2018 | $399,000 | -70.0% | 13,392 | -67.6% | 0.02% | -74.1% |
| Q4 2017 | $1,332,000 | +331.1% | 41,392 | +365.5% | 0.08% | +285.7% |
| Q3 2017 | $309,000 | -57.0% | 8,892 | -80.2% | 0.02% | -47.5% |
| Q2 2016 | $718,000 | +52.8% | 44,900 | +99.6% | 0.04% | +33.3% |
| Q1 2016 | $470,000 | – | 22,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |